Kimberlee Kossover Hansen, Commercial
Kimberlee Kossover Hansen is an Oncology specialist in the Northeast Region. Since joining Millennium, she has had roles in Commercial Quality Operations, Commercial Operations, and Compliance Operations. Kimberlee holds an MBA in International Business and a BA in International relations. She was crowned the 2010 Woman of the Year by the Leukemia & Lymphoma Society (LLS).
Chip Harris, Sales
Chip Harris is a Senior Oncology Sales Specialist. While working for Millennium, Chip has sold to and educated healthcare professionals about how VELCADE is used to treat multiple myeloma and mantle cell lymphoma patients. Chip has supported the field sales force in various roles, including The Marketing Advisory Board, Regional Trainer, and Reimbursement Liaison.
Erik Koenig, Discovery
Erik Koenig is a Senior Manager of Molecular Pathology. Over the past 12 plus years, while working for Millennium, Erik has managed several functions, with a focus on RNA and DNA technologies, to support Discovery Research. Erik is currently responsible for a variety of Discovery's genomic technology testing needs, data generation and establishing a pipeline for genomics to be used to support translational medicine.
Chuck Minor, Medical
Charles Minor is a Senior Manager in the Drug Development Management (DDM) group. He currently manages the development programs for Mifamurtide (L-MTP-PE) and TAK-441. Prior to joining the DDM group, Charles worked in Scientific Development, negotiating and managing licenses for R&D organization. Charles enjoys working with his talented colleagues on the development teams.
Ann Bissonnette, Non-clinical Development Sciences
Ann Bissonnette is a Senior Manager in Drug Safety Evaluation in the Non-clinical Development Sciences division. Drug Safety Evaluation defines potential hazards posed by therapeutic candidates in nonclinical test systems and prepares regulatory documents to support global clinical testing and registration. Ann coordinates the outsourcing and monitoring of the nonclinical development studies at Contract Research Organizations.